Zurich Cantonal Bank
HZNP

Zurich Cantonal Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Zurich Cantonal Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,249
Closed -$4.54M – 2821
2023
Q3 		$4.54M Sell
39,249
-58,069
-60% -$6.24M 0.02% 526
2023
Q2 		$10M Buy
97,318
+4,470
+5% +$472K 0.04% 357
2023
Q1 		$10.1M Buy
92,848
+56,443
+155% +$6.24M 0.05% 335
2022
Q4 		$4.14M Sell
36,405
-21,992
-38% -$1.83M 0.02% 517
2022
Q3 		$3.61M Buy
58,397
+9,750
+20% +$681K 0.02% 540
2022
Q2 		$3.88M Buy
48,647
+3,603
+8% +$341K 0.02% 528
2022
Q1 		$4.74M Sell
45,044
-34,686
-44% -$3.38M 0.02% 527
2021
Q4 		$8.59M Sell
79,730
-8,399
-10% -$916K 0.04% 391
2021
Q3 		$9.65M Buy
88,129
+11,048
+14% +$1.15M 0.05% 333
2021
Q2 		$7.22M Buy
77,081
+18,070
+31% +$1.66M 0.04% 394
2021
Q1 		$5.43M Sell
59,011
-11,678
-17% -$985K 0.03% 460
2020
Q4 		$5.17M Buy
70,689
+36,383
+106% +$2.7M 0.03% 478
2020
Q3 		$2.67M Sell
34,306
-16,058
-32% -$1.1M 0.02% 617
2020
Q2 		$2.8M Buy
50,364
+5,089
+11% +$218K 0.02% 534
2020
Q1 		$1.34M Buy
45,275
+31,259
+223% +$1.06M 0.01% 677
2019
Q4 		$507K Buy
14,016
+2,519
+22% +$77.2K ﹤0.01% 920
2019
Q3 		$313K Buy
11,497
+1,587
+16% +$41K ﹤0.01% 1041
2019
Q2 		$238K Hold
9,910
– – ﹤0.01% 1155
2019
Q1 		$262K Sell
9,910
-2,361
-19% -$55.9K ﹤0.01% 1075
2018
Q4 		$240K Buy
12,271
+1,149
+10% +$22.5K ﹤0.01% 1114
2018
Q3 		$218K Hold
11,122
– – ﹤0.01% 1255
2018
Q2 		$184K Hold
11,122
– – ﹤0.01% 1286
2018
Q1 		$158K Buy
11,122
+2,779
+33% +$41.1K ﹤0.01% 1332
2017
Q4 		$122K Buy
8,343
+3,133
+60% +$44K ﹤0.01% 1468
2017
Q3 		$66K Hold
5,210
– – ﹤0.01% 1642
2017
Q2 		$62K Buy
5,210
+715
+16% +$8.89K ﹤0.01% 1639
2017
Q1 		$66K Hold
4,495
– – ﹤0.01% 1607
2016
Q4 		$73K Hold
4,495
– – ﹤0.01% 1494
2016
Q3 		$81K Buy
4,495
+573
+15% +$11.2K ﹤0.01% 1394
2016
Q2 		$65K Hold
3,922
– – ﹤0.01% 1379
2016
Q1 		$65K Hold
3,922
– – ﹤0.01% 1334
2015
Q4 		$85K Buy
3,922
+2,266
+137% +$44.1K ﹤0.01% 1208
2015
Q3 		$33K Buy
1,656
+1,142
+222% +$36.1K ﹤0.01% 1328
2015
Q2 		$18K Buy
514
+179
+53% +$5.46K ﹤0.01% 1137
2015
Q1 		$9K Buy
+335
New +$6.14K ﹤0.01% 1462

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zurich Cantonal Bank's HZNP Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 39,249 shares — an estimated $4.54M sold.

Zurich Cantonal Bank first reported a position in HZNP in Q1 2015 and held it in 35 quarters. The position peaked at $10.1M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Zurich Cantonal Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 39,249 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.54M.
  • Zurich Cantonal Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 35 quarters.
  • Zurich Cantonal Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.